It is a pharma private limited company based in Thane, Maharashtra, India, established in 1989.
1989 | Thane, Maharashtra, India | ActiveGeetanjali Pharmaceuticals (India) P. Ltd., a active private limited company, was established on 15 September 1989 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U99999MH1989PTC053485. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.27 M.
It upholds a compliant status. Its leadership includes Sushmita Nimbalkar (Director), Jayashree Nimbalkar (Director), Ajay Ramchandra Nimbalkar (Managing Director). Past directors included Sanjay Ramrao Nimbalkar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-8/4, Sector No 4, Konkan Bhavan,, Cbd Belapur, Navi Mumbai, Thane, Maharashtra, 400614.
U99999MH1989PTC053485
053485
15 September 1989
₹0.50 M
₹0.27 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Geetanjali Pharmaceuticals (India) P. Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushmita Nimbalkar | Director | 16 Jun 2008 | Current |
| Jayashree Nimbalkar | Director | 16 Jun 2008 | Current |
| Ajay Ramchandra Nimbalkar | Managing Director | 19 Sep 1989 | Current |
| Kaustubh Nimbalkar | Director | 05 Jul 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Geetanjali Pharmaceuticals (India) P. Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 19.37% increase. The company also saw a substantial fall in profitability, with a 50.09% decrease in profit. The company's net worth moved up by a moderate rise of 1.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Geetanjali Pharmaceuticals (India) P. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Geetanjali Pharmaceuticals (India) P., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Geetanjali Pharmaceuticals (India) P., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geetanjali Pharmaceuticals (India) P.'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Geetanjali Pharmaceuticals (India) P. Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Geetanjali Pharmaceuticals (India) P. Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Kaustubh Nimbalkar was appointed as a Director was appointed as a Director on 05 Jul 2008 & has been associated with this company since 17 years 5 months . was completed.
Sushmita Nimbalkar was appointed as a Director was appointed as a Director on 16 Jun 2008 & has been associated with this company since 17 years 5 months . was recorded as a recent event.
Progress on Jayashree Nimbalkar was appointed as a Director was appointed as a Director on 16 Jun 2008 & has been associated with this company since 17 years 5 months . was documented.
Progress on Ajay Ramchandra Nimbalkar was appointed as a Managing Director was appointed as a Managing Director on 19 Sep 1989 & has been associated with this company since 36 years 2 months . was documented.
The CIN of Geetanjali Pharmaceuticals (India) P. Ltd. is U99999MH1989PTC053485.
Geetanjali Pharmaceuticals (India) P. Ltd. is headquartered at F-8/4, Sector No 4, Konkan Bhavan,, Cbd Belapur, Navi Mumbai, Thane, Maharashtra, 400614.
Geetanjali Pharmaceuticals (India) P. Ltd. was incorporated on 15 September 1989.
The current directors of Geetanjali Pharmaceuticals (India) P. Ltd. are
The primary industry of Geetanjali Pharmaceuticals (India) P. Ltd. is Pharma.
Geetanjali Pharmaceuticals (India) P. Ltd. is unlisted.
The authorized capital of Geetanjali Pharmaceuticals (India) P. Ltd. is ₹0.50 M, and the paid-up capital is ₹0.27 M.
The compliance status of Geetanjali Pharmaceuticals (India) P. Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX